Pridopidine for the treatment of ALS - Results from the phase 2 Healey ALS platform trial

Category Primary study
Conference10th Congress of the European Academy of Neurology
Year 2024
This article has no abstract
Epistemonikos ID: 0ef14561311f22c1f48dc6e6a081f436fd02ea03
First added on: Jan 10, 2026